Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer

Ling Yao; Yayun Chi; Xin Hu; Shan Li; Feng Qiao; Jong Wu; Zhi-Ming Shao

doi:10.18632/oncotarget.9656

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Clinical Research Papers:

Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer

Ling Yao, Yayun Chi, Xin Hu, Shan Li, Feng Qiao, Jong Wu and Zhi-Ming Shao _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:53895-53902. https://doi.org/10.18632/oncotarget.9656

Metrics: PDF 1515 views | HTML 2008 views | ?

Abstract

Ling Yao1,*, Yayun Chi1,*, Xin Hu1,*, Shan Li1, Feng Qiao1, Jong Wu1,2,3 and Zhi-Ming Shao1,2,3

1 Department of Breast Surgery, Fudan University, Shanghai Cancer Center and Cancer Institute, Shanghai, P.R. China

2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China

3 Institutes of Biomedical Science, Fudan University, Shanghai, P.R. China

* These authors have contributed equally to this work

Correspondence to:

Zhi-Ming Shao, email:

Jong Wu, email:

Keywords: BCDIN3D, breast cancer, TNBC

Received: October 12, 2015 Accepted: May 13, 2016 Published: May 28, 2016

Abstract

Background: BCDIN3D is a member of the Bin3 methyl-transferase family that targets the 5’ mono-phosphate of nucleic acids. Although BCDIN3D has been shown to increase tumorigenic phenotypes and invasiveness in MDA-MB-231 cells, its the clinical implications in breast cancer remain unclear. Methods: We screened for BCDIN3D using tissue microarrays constructed from 250 patients who were histologically confirmed to have invasive ductal breast carcinoma at the Fudan University Shanghai Cancer Center. Results: The survival analysis by Kaplan-Meier and Cox regression showed that BCDIN3D expression level served as a prognostic factor for disease-free survival (P = 0.042). The prognostic value of BCDIN3D was most significant in triple-negative breast cancer (TNBC) patients (P = 0.007). Conclusions: BCDIN3D might serve as an important prognostic factor for TNBC patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9656

Publication Alerts

Clinical Research Papers:

Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer

Abstract